PureTech Health plc (PRTC)

R&D to Revenue

1214.14%

Fiscal year · Period ending:

PRTC logo

PRTC R&D to Revenue

Latest reported1214.14%
PRTC FY R&D/Revenue (53.30% → 1214.14%)
High-resolution chart · PNG

PRTC r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

PureTech Health plc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
1,214.145%
1,257.9374%
12,831.3333%
5,555.6459%
816.9255%
733.5571%
750.0691%
349.9664%
11,026.4615%
929.9255%
114.2078%
140.9543%
40.3476%
53.3031%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.